Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Web Resources
|
Zolmax.com - American Consumer News: Lifesci Capital Comments on Tenaya Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:TNYA)Newstex Global Business Blogs, 2024Copyright Newstex May 18, 2024Digital Resources/Online E-Resources |
|
2 |
Material Type: Web Resources
|
Watchlist News - American Consumer News: Tenaya Therapeutics’ (TNYA) “Buy” Rating Reiterated at HC WainwrightNewstex Finance & Accounting Blogs, 2024Copyright Newstex May 18, 2024Digital Resources/Online E-Resources |
|
3 |
Material Type: Web Resources
|
Zolmax.com - American Consumer News: Tenaya Therapeutics (NASDAQ:TNYA) Price Target Cut to $16.00 by Analysts at Canaccord Genuity GroupNewstex Global Business Blogs, 2024Copyright Newstex May 20, 2024Digital Resources/Online E-Resources |
|
4 |
Material Type: Web Resources
|
Zolmax.com - American Consumer News: Q2 2024 Earnings Forecast for Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Issued By Leerink PartnrsNewstex Global Business Blogs, 2024Copyright Newstex May 18, 2024Digital Resources/Online E-Resources |
|
5 |
Material Type: Web Resources
|
Zolmax.com - American Consumer News: Analyzing Lexeo Therapeutics (NASDAQ:LXEO) and Repligen (NASDAQ:RGEN)Newstex Global Business Blogs, 2024Copyright Newstex May 20, 2024Digital Resources/Online E-Resources |
|
6 |
Material Type: Web Resources
|
American Banking and Market News - American Consumer News: Comparing Repligen (NASDAQ:RGEN) and Lexeo Therapeutics (NASDAQ:LXEO)Newstex Finance & Accounting Blogs, 2024Copyright Newstex May 18, 2024Digital Resources/Online E-Resources |